Halo Collective (BST:A9KN) - Cours de l'action, nouvelles et analyse

A9KN Aperçu des actions

Engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States.

A propos de l'entreprise

A9KN analyse fondamentale
Score flocon de neige
Évaluation	2/6
Croissance future	0/6
Performances passées	0/6
Santé financière	6/6
Dividendes	0/6

Récompenses

Analyse des risques

Earnings have declined by 48.7% per year over past 5 years

Does not have a meaningful market cap (€1M)

Shareholders have been substantially diluted in the past year

Shares are highly illiquid

Halo Collective Inc. Concurrents

Biofrontera

XTRA:B8FK

€17.4m

SynBiotic

DUSE:SBX

€31.9m

Redx Pharma

DB:0RX

€65.0m

Cantourage Group

XTRA:HIGH

€58.9m

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Halo Collective
Historique des cours de bourse
Prix actuel de l'action	US$0.26
Plus haut sur 52 semaines	US$4.07
Plus bas sur 52 semaines	US$0.066
Bêta	1.96
1Variation sur 1 mois	0%
Variation sur 3 mois	229.30%
Variation sur 1 an	-93.17%
3Variation sur 3 ans	-99.68%
Variation sur 5 ans	n/a
Évolution depuis l'introduction en bourse	-99.83%

Nouvelles et mises à jour récentes

Recent updates

Rendement pour les actionnaires

	A9KN	DE Pharmaceuticals	DE Marché
7D	0%	-1.8%	-1.8%
1Y	-93.2%	-12.8%	13.6%

Rendement vs Industrie: A9KN underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.

Rendement vs marché: A9KN underperformed the German Market which returned 5.9% over the past year.

Volatilité des prix

Is A9KN's price volatile compared to industry and market?
A9KN volatility
A9KN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	7.9%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.5%
10% least volatile stocks in DE Market	2.4%

Cours de l'action stable: A9KN's share price has been volatile over the past 3 months.

Volatilité au fil du temps: Insufficient data to determine A9KN's volatility change over the past year.

À propos de l'entreprise

Fondée	Salariés	PDG	Site web
2016	276	Katie Field	www.haloco.com

Halo Collective Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de Halo Collective se comparent-ils à sa capitalisation boursière ?
A9KN statistiques fondamentales
Capitalisation boursière	€1.10m
Bénéfices(TTM)	-€87.07m
Recettes(TTM)	€26.08m

0.0x

Ratio P/S

0.0x

Ratio P/E

Le site A9KN est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
A9KN compte de résultat (TTM)
Recettes	US$28.34m
Coût des recettes	US$24.54m
Marge brute	US$3.80m
Autres dépenses	US$98.41m
Les revenus	-US$94.61m

Derniers bénéfices déclarés

Sep 30, 2022

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)	-1.39
Marge brute	13.40%
Marge bénéficiaire nette	-333.86%
Ratio dettes/capitaux propres	18.3%

Quelles ont été les performances à long terme de A9KN?

Voir les performances historiques et les comparaisons

A9KN Aperçu des actions

Récompenses

Analyse des risques

Halo Collective Inc. Concurrents

XTRA:B8FK

€17.4m

DUSE:SBX

€31.9m

DB:0RX

€65.0m

XTRA:HIGH

€58.9m

Historique des prix et performances

Nouvelles et mises à jour récentes

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

Recent updates

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

Halo Collective Inc. Appoints Katie Field as Chairman of the Board

Halo Collective Receives All Regulatory Approvals for Its Third Budega Dispensary in Hollywood, Halo's First Superstore

Halo Collective Inc. announced that it has received $6 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance and other investors

Halo Collective Inc. announced that it has received $5.999994 million in funding

Halo Collective Inc. Announces Management Changes

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.56 loss in 1Q 2021)

Halo Collective Inc. Announces Resignation of Philip Van Den Berg as Chief Financial Officer

Halo Collective Inc. Receives Final Approvals from the Los Angeles Department of Cannabis Regulation & California Department of Cannabis Control and the State Department of Cannabis Control

High number of new directors

Full year 2021 earnings released: US$4.12 loss per share (vs US$7.27 loss in FY 2020)

Less than half of directors are independent

Halo Collective Announces Changes to Board of Directors

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. (OTCPK:HCAN.F) completed the acquisition of 1285826 B.C. Ltd. from 1337617 B.C. Ltd., 1253540 B.C. Ltd. and NKG Investments Ltd.

Halo Collective Inc. announced that it expects to receive CAD 14 million in funding from Alpha Blue Ocean Investment Group

Halo Collective Receives Local Approvals for Budega™ Dispensary in Los Angeles's Noho Arts District

Halo Collective Inc. (OTCPK:HCAN.F) entered into an agreement to acquire 1285826 B.C. Ltd. for $7 million.

Third quarter 2021 earnings released: US$0.40 loss per share (vs US$0.42 loss in 3Q 2020)

High number of new directors

High number of new directors

Halo Collective Inc. Announces the Official Launch of Ztrawberriez and 4 Prophets Premium Cannabis Flower

Halo Collective Inc. Announces FlowerShop, a Sensory-Care™ Brand Launches New Product Line, BUDVASE

Halo Collective Announces Reorganization of International Assets to Create Akanda

Halo Collective Inc. Provides Earnings Guidance for the Year 2021

Halo Collective Inc. Provides Sales Guidance for the Month Ended April 2021

Halo Collective Inc. announced that it expects to receive CAD 1 million in funding

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 10.000025 million.

PeakBirch Logic Inc. Announces Partnership with Halo Collective Inc. to Develop Functional Mushroom Line

Halo Collective Inc. Enters into Partnership with Nightingale Remedies (Nightingale) and PeakBirch Logic Inc

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 8.00154 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1275111 B.C. Ltd.

Halo Labs Inc. announced that it expects to receive CAD 2.25 million in funding

Chief Financial Officer recently sold €95k worth of stock

Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Third quarter 2020 earnings released: US$0.006 loss per share

Halo Labs Inc. Appoints Annmol Sidhu to the Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of CanMart Ltd from David Keith Dean and Darran William Quinn.

Fred Leigh Resigns to Halo Labs Inc.'s Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding Letter of Intent to acquire CanMart Ltd for CAD 4.6 million.

Halo Labs Inc. (OTCPK:AGEE.F) entered into an amended asset purchase agreement to acquire three operating KushBar retail cannabis stores from KushBar Inc. for CAD 3.4 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1265292 B.C. Ltd.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of the remaining 85.28% stake in Ukiah Ventures Inc. from Odyssey Trust Company and others.

Earnings released

Halo Labs Inc. (OTCPK:AGEE.F) entered into a share exchange agreement to acquire the remaining 85.28% stake in Ukiah Ventures Inc. for $6.5 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 66.7% stake in LKJ11 LLC.

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding agreement to acquire a dispensary in Los Angeles.

Rendement pour les actionnaires

Volatilité des prix

À propos de l'entreprise

Halo Collective Inc. Résumé des fondamentaux

0.0x

0.0x